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Abstract
Despite evidence that smoking behaviour increases in the context of stress, there has yet to be a clear-cut
demonstration that nicotine intake is similarly enhanced. Although nicotine intake has been shown to reduce
reported anxiety in the context of stress, the controlling conditions (type of stressor, intensity, temporal
relationships, etc.) need further exploration. Recent findings involving nicotine's effects on the hypophyseal-
adrenal axis provide a new perspective on these issues, in that increased nicotine intake during exposure to a
stressor may represent, at least in part, behavioral compensation for diminished sensitivity to nicotine brought
about by nicotine-stimulated corticosteroid release. Corticosteroids may decrease central nervous system
excitability in a way that could account for anxiety reduction; on the other hand, anxiety reduction may be an
epiphenomenon with respect to the reinforcement of smoking behaviour. The integration of behavioural,
physiological, and biochemical research exemplified by the above approach should lead to a better
understanding of stress and smoking.
Introduction
The relationship between stress and smoking, and a
corresponding link between smoking and anxiety
reduction, are so well entrenched in the lore
concerning cigarette smoking (see USDHHS, 1988,
pp. 394-414) that they have assumed the status of
truisms. A critical examination of the support for
these relationships is timely because (a) much
smoking does seem to occur in response to stress,
(b) relapse after quitting appears to be strongly
associated with dysphoric states, and (c) commonal-
ities in the neuroendocrine response to nicotine and
to stress suggest that a study of interactions may
yield useful knowledge about both phenomena. In
this brief review, we shall examine questions that we
believe must be addressed more systematically if
further progress is to be made. Key issues include:
(1) The relationship between stress and smoking—
is it real or apparent? (2) What are the controlling
conditions for anxiety reduction in the reinforce-
ment of smoking? (3) What are the biological
mechanisms entrained by smoking in the context of
stress, and how do they contribute to subjective and
behavioural phenomena?
The relationship between stress and smoking
Smokers commonly report smoking more under
conditions experienced as stressful, and it has been
suggested that smoking is a technique for dealing
with stress. Prospective studies have found associa-
tions between anxious, aggressive, and generally
neurotic personality traits in childhood and a
tendency to smoke later in life. Using a cross-
sectional sample of 668 adults, Billings & Moos
(1983) found that smokers, especially heavy smok-
ers, differed from non-smokers in showing higher
levels of anxiety/depression symptoms and negative
life events.
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Analysis of the circumstances surrounding recidi-
vism supports the stress-smoking link. In a prospec-
tive study of predictors of outcome in 100 treated
smokers, Pomerleau et al. (1978) found that relapse
was predicted by the smoker's identifying 'negative
affect' as the context in which smoking was most
likely to occur. Similarly, Shiffman (1982) found
that most relapse crises in ex-smokers who utilized
the services of a relapse-counseling 'hotline' were
associated with negative affect, particularly anxiety
(which was twice as frequent as the next most
common antecedent affect); in over half of the crisis
episodes, no other nicotine withdrawal symptoms
were reported.
Laboratory studies have strengthened the infer-
ence of a causal link between stress and smoking.
Schachter (1978) showed in a series of studies that
naturalistic stressors such as public speaking, simu-
lated airplane noise, and electric shocks were
associated with sharp increases in smoking, as
measured by number of cigarettes lighted up. Other
experimenters (Dobbs et al., 1981; Pomerleau &
Pomerleau, 1987; Rose et al., 1983) have also
reported increased smoking in response to stress,
using more precise measures of smoking topogra-
phy. A definitive demonstration that psychological
stress reliably increases nicotine intake, however,
has yet to be reported. What will be needed are well-
controlled studies that include measures of plasma
nicotine and explore systematically parameters re-
lating to the nature and timing of the stressor. Also
needed is an investigation of the possibility that a
disjunction between nicotine intake and smoking
behavior exists (and that observed increases in
smoking represent a form of adjunctive behavior
rather than increases in nicotine self-administra-
tion). Larger studies focusing on individual differ-
ences will be required to determine whether stress
induction of smoking is more pronounced in some
people than in others.
The controlling conditions for anxiety
reduction from smoking
Reduction of anxiety via nicotine self-administra-
tion is the principal hypothesis offered to explain
reinforcement for smoking in the context of stress.
Nesbitt (1973) and Silverstein (1982) reported that
aversive shock thresholds increased in proportion to
the nicotine content of cigarettes smoked; Silver-
stein (1982) speculated that this phenomenon was a
manifestation of anxiety reduction caused by nico-
tine, but no measurement of either nicotine intake
or changes in anxiety was made. Other studies have
indicated more direct effects of smoking on dys-
phoric mood states. For instance, Schachter (1978)
reported that heavy smokers were more irritable
during exposure to simulated plane overflights when
they were totally deprived of smoking or smoked
low nicotine cigarettes. Smokers who smoked high
nicotine cigarettes, however, were no less irritable
than non-smokers exposed to the same stressor. In
another study using noise stress, Woodson et al.
(1983) also found that anticipatory smoking dimin-
ished self-reported anxiety.
Pomerleau et al. (1984) reported smoking-related
reductions in cold-pressor pain and in anxiety
generated in anticipating presentation of a difficult
anagram. A subsequent study involving only cold-
pressor pain (Fertig et al., 1986) demonstrated these
effects to be dose-related, both in minimally-
deprived smokers and ex-smokers. These findings,
combined with related research with nicotine-naive
animals, support the existence of nicotine effects
independent of relief of nicotine withdrawal. The
definitive test at the human level, however, will
require administration of nicotine to never-smokers.
Jarvik et al. (1989) recently examined anticipa-
tory anxiety for four stressors: Anxiety generated by
anticipation of auditory vigilance or of white noise
was not reduced by smoking and anxiety in anticipa-
tion of cold pain was marginally reduced, whereas
anxiety in anticipation of a difficult anagram was
significantly dampened by smoking. Uncontrolled
factors that may have contributed to these effects
include sensory modality and social context (sub-
jects were observed during the anagram and cold
pain conditions but not the vigilance and white noise
conditions) as well as relative intensity. Jarvik
speculated that the temporal relationship between
the stressor and smoking was important, since even
when smoking diminished pre-task anxiety, post-
task anxiety was not affected. Subsequent research
by Jarvik and colleagues (Caskey, personal com-
munication, 1990) has indicated that when it does
occur, anxiety reduction following smoking is tran-
sitory, coinciding with the sharp rise in plasma
nicotine. Thus, the phenomenon of anxiety-reduc-
tion may be limited to a brief period following
smoking. A limitation of this and other studies of
anxiolysis of nicotine carried out to date is that
nicotine was self-administered, typically via ciga-
rette smoking. Controlled dosing methodologies that
are less dependent on drug-ingestive behaviors such
as inhaling, snuffing, etc. are essential to prevent
behavioral compensation in response to nicotine
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deprivation, satiation, stress, demand character-
istics, etc. (Pomerleau et al., 1989).
Biological mechanisms in smoking and stress
Although progress has been made, the elusiveness of
the relationship between stress and smoking sug-
gests that new paradigms identifying underlying
biological mechanisms will be needed if we are to
extend our understanding of this phenomenon.
Schachter (1978) offered an early alternative to the
anxiety-reduction hypothesis; noting that acidifica-
tion of urine by a stressor increases nicotine
excretion, he speculated that the resulting nicotine
withdrawal might be perceived as anxiety and
compel replacement of nicotine by increased smok-
ing. This explanation had some appeal, since it
obviated the necessity of relying exclusively on an
interventing variable—anxiety—that was hard to
define and measure; but subsequent parametric
experimentation manipulating urinary pH (Rosen-
berg et al, 1980) failed to support the hypothesis.
Recent work by Winders (personal communication,
1990), however, demonstrated significantly lower
blood nicotine levels in rats exposed over 2.5 hours
to psychological and physical stressors than in
unstressed animals. These findings suggest that
prolonged or severe stress could diminish nicotine
availability, resulting in withdrawal and presumably
in compensatory intake.
We have recently become intrigued by the
possibility that the hypophyseal-adrenal axis may
provide important clues for understanding stress-
induction of smoking when it occurs, as well as
explanatory mechanisms capable of incorporating
what has been learned about anxiety reduction in
smoking. ACTH, the hormone that stimulates
corticosteroid release, is a hypophysical peptide
under the control of corticotropin releasing hor-
mone in the hypothalamus (see Pomerleau &
Rosecrans, 1989). Nicotine, in a dose-related man-
ner, has been shown to stimulate release of ACTH
in an isolated perfused mouse brain preparation
(Marty et al., 1985) and, in intact rats, to increase
the levels of plasma ACTH and corticosterone (the
major corticosteroid for rodents) (Conte-Devolx et
al., 1981). Pomerleau and colleagues (Pomerleau et
al., 1983; Seyler et al., 1984), in a series of studies
on cigarette smokers, demonstrated significant,
dose-related increases in circulating ACTH and
cortisol following the smoking of high-nicotine
cigarettes after overnight deprivation.
A series of studies recently conducted by Collins
and his colleagues has helped to characterize the
relationship between nicotine and stress. Using
inbred mice, Freund et al. (1988) demonstrated
consistent strain differences in corticosteroid stimu-
lation by nicotine; the effect was abolished by
mecamylamine, substantiating the involvement of a
nicotinic cholinergic receptor. Moreover, strain-
specific differences in the endogenous corticoster-
one response were paralleled by behavioral and
physiological differences in sensitivity to nicotine.
Thus, individual differences in responsiveness to
nicotine in mice were found to be stable and
genetically based. In a study by Pauly et al. (1988),
adrenalectomized mice exhibited greatly enhanced
sensitivity to the effects of nicotine, with significant
dose-related increases in acoustic startle response
and decreases in Y-maze activity, heart rate, and
core temperature, though nicotinic cholinergic re-
ceptor number was unaffected and nicotine metabo-
lism unchanged. Administration of exogenous corti-
costerone restored protection from the effects of
nicotine in the adrenalectomized animals. Adminis-
tration of corticosterone to non-adrenalectomized
animals further decreased sensitivity to nicotine,
supporting the hypothesis that nicotine's own cori-
costeroid response (rather than ACTH changes,
etc.) reduced the sensitivity of nicotine receptors.
Collins and his associates (personal communication,
1989) have subsequently found that extended expo-
sure to nicotine produces dose-related decreases in
nicotine stimulation of corticosterone, indicating
that the nicotinic receptor involved in corticosteroid
regulation is also subject to diminution of sensitivity
as a result of chronic dosing.
To determine whether similar effects might occur
in humans, we manipulated corticosteroid levels by
administering dexamethasone (a synthetic corticost-
eroid) and used magnitude of cortisol stimulation by
nicotine as a marker of sensitivity to nicotine
(Pomerleau & Pomerleau, 1990). As hypothesized,
there was a significant dampening of the cortisol
response to nicotine following administration of
dexamethasone the night before. There was also a
trend towards a significant correlation between
cortisol increases for the dexamethasone and pla-
cebo conditions, suggesting characteristic individual
differences in response to nicotine. We plan to
replicate these observations in a larger sample of
smokers, using a variety of synthetic corticosteroids
and additional physiological and behavioral mea-
sures of sensitivity to nicotine.
Recently, Morse (1989) reported that restraint
stress and repeated acute nicotine dosing produce
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additive effects upon circulating corticosterone in
rabbits. Again, to determine whether psychological
stress and nicotine administration via smoking
might also produce additive effects in humans, we
exposed moderate smokers to stress and/or nicotine
in four successive sessions (Pomerleau & Pomer-
leau, 1990). Cortisol levels were elevated by smok-
ing and by stress separately, and the two in
combination had an additive effect, suggesting that
psychological stressors exacerbate the corticosteroid
response to nicotine, potentially reducing sensitivity
to nicotine still further.
Although the research on corticosteroids de-
scribed above is still preliminary, we believe that it
shows potential for increasing our understanding of
various smoking-related phenomena. The demon-
stration that nicotine and/or stress cause corticost-
eroid release provides a novel way of explaining
interactions between smoking and stress, for it
suggests that increased nicotine intake during expo-
sure to a stressor may represent, at least in part,
behavioral compensation for diminished sensitivy to
nicotine. While corticosteroid mechanisms might
paly a role in the reduction of anxiety by smoking,
there is also the possibility that anxiety reduction
following nicotine self-administration in the context
of stress is simply an epiphenomenon, an effect
frequently associated with but not critical to in-
creased smoking behavior.
In normal humans, the initial response to an acute
stressor is stimulation of metabolic, neuronal, infl-
ammatory, and immune activity, mediated in part
by adrenergic activity resulting in increased sympa-
thetic tone and catecholamine levels. With chronic
or severe stress, however, the hypophyseal-adreno-
cortical system is also entrained, and endogenous
opioids and corticosteroids are released. According
to recent theory (Munck et al., 1984), stress-
induced increases in corticosteroid levels function
not to protect against the source of stress itself (as
was originally hypothesized by Selye, 1956), but
rather to set homeostatic limits on the primary
defense mechanisms. The secondary (hypophyseal-
adrenocortical) response to stress is sufficiently
delayed in relation to the initial stress response to
allow appropriate protective mechanisms to become
activated. After the corticosteroids have countered
the primary adrenergic response, activity of the
pituitary-adrenal axis is reduced through a negative
feedback process.
Nicotine administration via smoking may be
adaptive on a short-term basis, increasing the
availability of hormones that protect against pertur-
bations from the primary stress-response. On the
other hand, if both stress and nicotine act via the
same or a related population of receptors, then the
tolerance to nicotine that develops in the chronic
heavy smoker may dampen the hypophyseal-adrenal
response to stress. Some support is provided by
recent findings by Shiffman and Kassel (personal
communication, 1990) in which occasional, light
smokers ('chippers') evinced greater cortisol reacti-
vity to the same dose of nicotine than regular, more
nicotine-dependent smokers. Thus, chronic smokers
may come to use smoking as a pharmacological
coping response to maintain normal metabolic
function in the context of stressful stimulation.
Over time, however, diminished corticosteroid reac-
tivity resulting from either chronic stress or regular
nicotine intake may increase the amount of nicotine
needed, thwarting the chronic smoker's attempts to
achieve metabolic balance.
While the functional implications suggested
above go beyond what is known unambiguously, the
ideas are testable using present methodologies.
Moreover, since investigation of a single system is
unlikely to provide 'the' explanation for the rela-
tionship between stress and smoking, the contribu-
tions of other mechanisms, such as brain electrophy-
siology, altered perceptual thresholds, and hypotha-
lamic consummatory drive reduction (LJSDHHS,
1988), as well as the patterns of release and
turnover of other neuroregulators, such as the
catecholamines, serotonin, and the endogenous
opioids (Pomerleau & Pomerleau, 1984), will need
to be taken into account if a comprehensive
understanding of smoking in the context of stress is
to emerge.
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